Drug
ensartinib
Marketed as ENSACOVE.
Generic name
ensartinib
Brand names
ENSACOVE
First FDA approval
2024-12-18
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA218171 | ENSACOVE | 2024-12-18 | XCOVERY |
Manufacturers
XCOVERY
Frequently asked questions
When was ensartinib FDA approved?
Earliest FDA approval on record: 2024-12-18.
What brand names are sold as ensartinib?
ENSACOVE.
Sources
Appeal a ensartinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com